Core Viewpoint - Brain动极光-B (06681) has seen a significant stock price increase, rising over 83% to a new high of 13.78 HKD since its listing, with a cumulative increase of 1.3 times since its debut [1] Group 1: Stock Performance - As of the latest update, the stock price has increased by 61.73%, trading at 12.13 HKD with a transaction volume of 1.054 billion HKD [1] - The stock was officially included in the Hong Kong Stock Connect list starting September 8 [1] Group 2: Company Overview - Brain动极光 is the first domestic company to develop medical-grade digital therapy products targeting cognitive disorders [1] - Its core product is the first cognitive disorder digital therapy product in China to receive regulatory approval, obtaining its first registration certificate in September 2018 [1] Group 3: Product Features - The company's products have recently received the Beijing New Technology, New Product, and New Service Certificate [1] - The products focus on intelligent assessment and precise intervention, featuring advantages such as precise evaluation based on large sample norms, multi-modal refined assessment to enhance intervention effectiveness, and an intelligent digital diagnosis and treatment platform that overcomes situational limitations [1]
港股异动 | 脑动极光-B(06681)一度大涨83%创新高 入通以来股价累涨超1.3倍